Our Mission
The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, education and advocacy.
Latest News
-
5 February 2025Trends and Outcomes in EVLP on JHLT: The Podcast
-
30 January 2025ISHLT Endorses the 2025 Karolinska Cardiogenic Shock Days Conference
-
27 January 2025January Journal Watch Explores Recent Cardiology Topics
ISHLT now has an online store where you can purchase merch! Visit the ISHLT Store and check out the featured products, incljuding special ISHLT2024 items.
Shop the ISHLT Store
ISHLTconnect is an online discussion platform open to anyone involved in the management and treatment of advanced heart and lung disease, transplantation, mechanical circulatory support, and pulmonary vascular disease. Members get complete access to all interdisciplinary discussion groups, while nonmembers can explore ten Professional Community boards.
Log InUpcoming Events
-
6 February, 2025 2:00 p.m. to 3:00 p.m. ESTGoing into the Mountains of MCS-land
A follow-up to the previous Anesthesiology & Critical Care Professional Community webinar entitled The Borders of MCS-land, this one hour webinar is designed as an in depth review of topics and higher levels of care in MCS. -
11 to 13 February, 20252025 Technology and Heart Failure Therapeutics Conference
The 2025 Technology and Heart Failure Therapeutics Conference is your premier destination for accessing pioneering data and comprehensive updates on heart failure treatments. The event will take place 11-13 February at the Omni Boston Hotel at the Seaport in Boston, MA USA.Boston, MA, USA -
-6.jpg?sfvrsn=cf7853c9_3)
18 February, 2025 2:00 p.m. to 3:00 p.m. ESTActive Inflammatory End-Stage Heart/Lung Diseases: To Do or Not to Do?
This session will explore the issues specific to patients with inflammatory pathologies requiring heart and/or lung transplantation. It will also examine the outcomes of these patients and the problems associated with native pathologies.
and Lung Transplantation
